Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

NCT01368887 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

160

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor seeking additional financial support before starting the study

Conditions

Psoriasis

Interventions

DRUG: DPS-102
OTHER: Vehicle / Placebo
DRUG: Calcipotriol Monotherapy
DRUG: Nicotinamide Monotherapy

Sponsor

DermiPsor, Ltd.